A detailed history of Consonance Capital Management LP transactions in Surrozen, Inc. stock. As of the latest transaction made, Consonance Capital Management LP holds 3,497,500 shares of SRZN stock, worth $38.3 Million. This represents 97.05% of its overall portfolio holdings.

Number of Shares
3,497,500
Previous 3,497,500 -0.0%
Holding current value
$38.3 Million
Previous $10.5 Million 32.67%
% of portfolio
97.05%
Previous 44.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$6.0 - $9.92 $15 Million - $24.8 Million
2,497,500 Added 249.75%
3,497,500 $22.4 Million
Q3 2021

Nov 15, 2021

BUY
$6.98 - $12.03 $6.98 Million - $12 Million
1,000,000 New
1,000,000 $6.72 Million

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $384M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.